* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Gene Section MELK (maternal embryonic leucine zipper kinase) in Oncology and Haematology
Cancer epigenetics wikipedia , lookup
Protein moonlighting wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Gene expression profiling wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Epigenetics in stem-cell differentiation wikipedia , lookup
Oncogenomics wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
BRAF (gene) wikipedia , lookup
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Gene Section Short Communication MELK (maternal embryonic leucine zipper kinase) Jean-Pierre Tassan CNRS UMR 6061 Universite de Rennes 1, IFR140 GFAS, Faculte de medecine, 2 avenue du Professeur Leon Bernard, CS 34317, 35043 Rennes Cedex, France (JPT) Published in Atlas Database: November 2011 Online updated version : http://AtlasGeneticsOncology.org/Genes/MELKID43360ch9p13.html DOI: 10.4267/2042/47299 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2012 Atlas of Genetics and Cytogenetics in Oncology and Haematology Identity undetectable in cells which have exited cell cycle (Badouel et al., 2010). Other names: HPK38, KIAA0175, pEg3 kinase HGNC (Hugo): MELK Location: 9p13.2 Localisation DNA/RNA The exact function of MELK is currently unknown, however MELK was shown to be involved in cell cycle progression via the protein phosphatase CDC25B phosphorylation (Blot et al., 2002), in cytokinesis (Le Page et al., 2011), in apoptosis via its interaction with the Bcl-2 family of proapoptotic genes (Lin et al., 2007) and apoptosis signal-regulating kinase (ASK1) (Jung et al., 2008) and in inhibition of mRNA splicing during mitosis via its association with NIPP1 (Vulsteke et al., 2004). MELK function is required for mammary tumorigenesis in vivo (Hebbard et al., 2010). Cytoplasm, nucleus and cell cortex. Function Description The gene encompasses 105 kb; it has 18 exons. Transcription The MELK gene generates multiple variants (potentially 28 different mRNAs). The longest mRNA is composed of 3218 nucleotides. Protein Note MELK (Maternal Embryonic Leucine zipper Kinase) belongs to the CAMK serine/threonine protein kinase superfamily. Melk is a protein serine/threonine kinase that is maximally active during mitosis. It is involved in diverse functions such as cell cycle, cytokinesis, mRNA splicing and apoptosis. Homology Description Various cancers The full-length protein is 651 amino acids with an estimated molecular weight of approximately 74,5 kDa. Note Expression of MELK is more elevated in multiple cancers including colon, lung and ovary relative to corresponding normal tissues. Elevated MELK expression is correlated with cell transformation (Gray et al., 2005). MELK belongs to the Kin1/PAR-1/MARK family of protein kinases found from yeast to human. These kinases are involved in cell polarity, dynamics of microtubules and intracellular signalisation. Implicated in Expression MELK is expressed in cells of various tissue origins. MELK is highly expressed in oocytes, spermatogonia and embryos, which is indicative of a role in the germcell development. MELK is highly expressed in a large panel of cancers. MELK expression is dependant on cell transformation (Gray et al., 2005). Its expression is strongly dependant on cell-cycle: MELK is Atlas Genet Cytogenet Oncol Haematol. 2012; 16(4) Brain tumors Note Expression of MELK was significantly higher in highly invasive glioblastomas multiform compared to benign 273 MELK (maternal embryonic leucine zipper kinase) Tassan JP Jung H, Seong HA, Ha H. Murine protein serine/threonine kinase 38 activates apoptosis signal-regulating kinase 1 via Thr 838 phosphorylation. J Biol Chem. 2008 Dec 12;283(50):34541-53 pilocytic astrocytomas (Marie et al., 2008). Prognosis Elevated MELK expression is associated with more aggressive behaviour and associated with poor prognosis of glioblastomas patients (Marie et al., 2008; Nakano et al., 2008). Marie SK, Okamoto OK, Uno M, Hasegawa AP, Oba-Shinjo SM, Cohen T, Camargo AA, Kosoy A, Carlotti CG Jr, Toledo S, Moreira-Filho CA, Zago MA, Simpson AJ, Caballero OL. Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas. Int J Cancer. 2008 Feb 15;122(4):807-15 Breast cancer Note MELK expression was found significantly upregulated in the breast cancers (Pickard et al., 2009). Prognosis MELK expression is associated with poor patient survival. Nakano I, Masterman-Smith M, Saigusa K, Paucar AA, Horvath S, Shoemaker L, Watanabe M, Negro A, Bajpai R, Howes A, Lelievre V, Waschek JA, Lazareff JA, Freije WA, Liau LM, Gilbertson RJ, Cloughesy TF, Geschwind DH, Nelson SF, Mischel PS, Terskikh AV, Kornblum HI. Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells. J Neurosci Res. 2008 Jan;86(1):48-60 References Pickard MR, Green AR, Ellis IO, Caldas C, Hedge VL, Mourtada-Maarabouni M, Williams GT. Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer. Breast Cancer Res. 2009;11(4):R60 Blot J, Chartrain I, Roghi C, Philippe M, Tassan JP. Cell cycle regulation of pEg3, a new Xenopus protein kinase of the KIN1/PAR-1/MARK family. Dev Biol. 2002 Jan 15;241(2):32738 Badouel C, Chartrain I, Blot J, Tassan JP. Maternal embryonic leucine zipper kinase is stabilized in mitosis by phosphorylation and is partially degraded upon mitotic exit. Exp Cell Res. 2010 Aug 1;316(13):2166-73 Vulsteke V, Beullens M, Boudrez A, Keppens S, Van Eynde A, Rider MH, Stalmans W, Bollen M. Inhibition of spliceosome assembly by the cell cycle-regulated protein kinase MELK and involvement of splicing factor NIPP1. J Biol Chem. 2004 Mar 5;279(10):8642-7 Hebbard LW, Maurer J, Miller A, Lesperance J, Hassell J, Oshima RG, Terskikh AV. Maternal embryonic leucine zipper kinase is upregulated and required in mammary tumor-initiating cells in vivo. Cancer Res. 2010 Nov 1;70(21):8863-73 Gray D, Jubb AM, Hogue D, Dowd P, Kljavin N, Yi S, Bai W, Frantz G, Zhang Z, Koeppen H, de Sauvage FJ, Davis DP. Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancers. Cancer Res. 2005 Nov 1;65(21):9751-61 Le Page Y, Chartrain I, Badouel C, Tassan JP. A functional analysis of MELK in cell division reveals a transition in the mode of cytokinesis during Xenopus development. J Cell Sci. 2011 Mar 15;124(Pt 6):958-68 Lin ML, Park JH, Nishidate T, Nakamura Y, Katagiri T. Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family. Breast Cancer Res. 2007;9(1):R17 Atlas Genet Cytogenet Oncol Haematol. 2012; 16(4) This article should be referenced as such: Tassan JP. MELK (maternal embryonic leucine zipper kinase). Atlas Genet Cytogenet Oncol Haematol. 2012; 16(4):273-274. 274